News

A new bispecific antibody therapy, AFM28, has shown strong preclinical results in targeting treatment-resistant cells in acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS), according to new research.

Intermittent fasting decreased symptoms of long COVID-19 in a randomised crossover trial that compared the efficacy and safety of 4 weeks of 1–2-day fasting plus a restricted diet versus 4 weeks of mild time-restricted eating and a restricted diet

Silymarin, vitamin E, and phospholipids combination therapy effectively reduces liver steatosis, fibrosis, and metabolic risk in MASLD.

Discover how stopping smoking may improve recovery from other addictions and why treatment programmes should integrate both.

A new study reveals that over a third of Indian rheumatoid arthritis patients experience methotrexate intolerance, with many reporting symptoms like nausea and abdominal discomfort.

A Vietnamese retrospective study challenges the push for endoscopy within 12 hours in patients with esophageal variceal bleeding.

Discover a study comparing intralesional triamcinolone and methotrexate for alopecia areata, revealing superior regrowth and patient satisfaction with triamcinolone.

TriCLASP study confirms PASCAL T-TEER safely reduces tricuspid regurgitation and improves symptoms and quality of life.